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Abstract
The vertebrate skull vault forms almost entirely by the direct mineralisation of mesenchyme, without the formation of a cartilaginous
template, a mechanism called membranous ossification. Dlx5 gene mutation leads to cranial dismorphogenesis which differs from the
previously studied craniosynostosis syndromes [Development 126 (1999), 3795; Development 126 (1999), 3831]. In avians, little is known
about the genetic regulation of cranial vault development. In this study, we analyze Dlx5 expression and regulation during skull formation
in the chick embryo. We compare Dlx5 expression pattern with that of several genes involved in mouse cranial suture regulation. This
provides an initial description of the expression in the developing skull of the genes encoding the secreted molecules BMP 2, BMP 4, BMP
7, the transmembrane FGF receptors FGFR 1, FGFR 2, FGFR 4, the transcription factors Msx1, Msx2, and Twist, as well as Goosecoid
and the early membranous bone differentiation marker osteopontin. We show that Dlx5 is activated in proliferating osteoblast precursors,
before osteoblast differentiation. High levels of Dlx5 transcripts are observed at the osteogenic fronts (OFs) and at the edges of the suture
mesenchyme, but not in the suture itself. Dlx5 expression is initiated in areas where Bmp4 and Bmp7 genes become coexpressed. In a
calvarial explant culture system, Dlx5 transcription is upregulated by BMPs and inhibited by the BMP-antagonist Noggin. In addition, FGF4
activates Bmp4 but not Bmp7 gene transcription and is not sufficient to induce ectopic Dlx5 expression in the immature calvarial
mesenchyme. From these data, we propose a model for the regulatory network implicated in early steps of chick calvarial development.
© 2003 Elsevier Science (USA). All rights reserved.
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Introduction
The vertebrate skull is formed by the precise assembly of
bony and cartilaginous elements which protect the brain, its
associated sensory organs, and the oral and nasal cavities,
while expanding to allow and follow brain growth during
embryonic and postnatal life. Close interactions between the
developing skull and its underlying tissues, such as the dura
mater, control the formation and differentiation state of the
edges of the bony plates, at the level of the cranial sutures
(Opperman et al., 1998; Kim et al., 1998; see Opperman,
2000 for a review). During evolution, the huge development
of the telencephalic hemispheres coincides with the recruit-
ment of the neural crest cells to form the “new head” (Gans
and Northcutt, 1983; Le Douarin and Kalcheim, 1999).
While the mesoderm-derived skeleton forms by endochon-
dral ossification, the bones of neural crest origin form either
cartilage or directly ossify from a mesenchymal state form-
ing “dermal” or “membranous” bones. The frontal, parietal,
exoccipital, and squamosal bones, which form the major
part of the avian skull vault, all undergo membranous ossi-
fication. They are surrounded by tissue layers also derived
from the neural crest, namely the dura mater and the dermis
(Couly et al., 1993).
Recent studies in the mouse have identified gene activ-
ities implicated in the late stages of calvarial development,
i.e., suture formation, maintenance, and obliteration (for a
review, see Opperman, 2000). The open suture, formed by
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dense connective tissue, is an area of growth between two
osseous plates (Julian et al., 1957; Oudhof, 1982). The
proliferating cells are located laterally rather than in the
center of the suture area (Opperman et al., 1998; Iseki et al.,
1999). Lining the proliferating zone, the edges of the de-
veloping bones—or osteogenic fronts (OFs)—undergo dif-
ferentiation (Decker and Hall, 1985). The suture area is
progressively obliterated by the fusion of these adjacent
bones, this process being completed only during adulthood
in humans. Alteration in this developmental process leads to
severe malformations of the skull vault, either by defective
bone development (cleidocranial dysplasia) or by premature
differentiation of the sutural mesenchyme (craniosynostosis
syndromes). The genetic analysis of human and murine
syndromes allowed the identification of mutations in vari-
ous genes associated with suture development. FGFRs are
implicated in the Pfeiffer mutation (FGFR1-2 genes; Schell
et al., 1995; Bellus et al., 1996), the Crouzon, Jackson-
Weiss and Apert syndromes (FGFR2/Bey locus and
FGF3-4 genes; Jabs et al., 1994; Galvin et al., 1996; Ander-
son et al., 1998; Carlton et al., 1998), and the Muenke
craniosynostosis (FGFR3; Muenke et al., 1997). TWIST has
Fig. 1. Dlx5 expression during chick skull development. (A, A, E, F, I) E9; (B, B, G, J) E12; (C, C, C, H, K) E16. (A–C) Dorsal views of in toto staining
for bone (red) and cartilage (blue). (A–C) Transverse sections at levels indicated in (A–C). Arrows indicate the OFs, separated by the suture (s). (C, C)
At E16, the frontal bones are thicker and separated by a reduced sutural mesenchyme (s, stained in pink at background levels). (D) Scheme of an E7 transverse
section. Dlx5 expression is found in the deep mesenchyme (light grey) and the ectoderm (dark grey) and is absent from the dermis. The area enlarged in the
following panels is boxed. (E–K) In situ hybridization with Dlx5 (E–H) and osteopontin (I–K) probes. (F/I), (G/J), and (H/K) are adjacent sections; (H) and
(K) are stained with Alizarin red after the in situ procedure. (E) At E9, posteriorly to frontal bones, Dlx5 transcripts are found as two bilateral mesenchymal
areas (one side is shown). (F–H) As differentiation proceeds, Dlx5 is detected all around the ossification areas and is upregulated at the level of the major.
(I) At E9, differentiating osteoblasts express the osteopontin gene. (J, K) Osteopontin is expressed in the differentiating osteoblasts but not in the mature
osteocytes (embedded into the Alizarin red-stained bone matrix). f, p, n, so: frontal, parietal, nasal, and supraoccipital bones, respectively.
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been involved in the Saethre-Chotzen syndrome (el Ghouzzi
et al., 1997) and MSX2 in Boston-type craniosynostosis
(Jabs et al., 1993). In vivo and in vitro studies conducted in
the mouse have defined a model for the genetic network that
implicates FGF2/4-FGFR1-3, BMP4-Msx2, TGF 2/3, and
Twist genes in the regulation of cell proliferation, apoptosis,
and differentiation in the sutures and the adjacent OFs
development (Iseki et al., 1997, 1999; Kim et al., 1998; Rice
et al., 2000; Opperman et al., 2000).
Dlx5 is a new candidate gene implicated in skull forma-
tion (Depew et al., 1999; Acampora et al., 1999). In the Dlx
family of homeobox genes, Dlx5 and Dlx6 present the
unique property of being expressed in all skeletal elements.
In the mouse or rat embryo, Dlx5 and Dlx6 transcripts are
present in immature chondrocytes, developing skull bones,
and periosteum of more mature bones (Acampora et al.,
1999). Both genes display closely related patterns of ex-
pression up to 12.5 dpc in mouse. Later on, Dlx6 expression
decreases, whereas Dlx5 remains strongly in the periosteum
and the skull (Acampora et al., 1999). In the Dlx5/
mutant embryos, almost every bone of the skull and cranio-
facial structures is affected, either by primary or by second-
ary defects. In particular, parietal and interparietal ossifica-
tion is almost absent, suggesting that, in these structures,
Dlx5 lack of activity is not compensated by another Dlx
family member such as Dlx6 (Depew et al., 1999). Redun-
dancy between these two genes has been demonstrated
recently in the double knock out of both Dlx5 and Dlx6 that
results into mouse embryos without calvaria, in addition to
other severe skeletal defects (Robledo et al., 2002). How-
ever, in vitro studies using murine cell lines have shown a
series of contradictory results about Dlx5 expression and
activity. Briefly, Dlx5 has been found in the differentiating
calvaria osteoblasts. Both Dlx5 and osteocalcin gene ex-
pression are upregulated during the mineralization phase,
but according to the cell line studied, Dlx5 overexpression
either represses osteocalcin gene activity (Ryoo et al., 1997)
or induces it (Miyama et al., 1999). DLX5 protein binds
osteoblast-specific elements present in the Bone SialoPro-
tein (BSP) promotor (Benson et al., 2000) and interacts with
transcription factors of other families. In particular, Dlx5,
Msx1, and Msx2 can bind one to another and antagonise
their respective activities (Zhang et al., 1997). For example,
Dlx5 suppresses Msx2 repression of osteocalcin gene tran-
scription (Newberry et al., 1998) in accordance to their
differential expression in proliferating (Msx2) and differen-
tiating (Dlx5) osteoblasts (Ryoo et al., 1997). Finally,
BMP2 upregulates Dlx5 expression in mouse whole em-
bryos and in osteoblast in culture (Miyama et al., 1999).
While the formation of the facial and hypobranchial
skeleton has been extensively studied in avians, gene activ-
ities during skull vault development remain to be docu-
mented. In this study, we detail Dlx5 gene expression and
regulation during calvarial formation, in relationship to the
BMP and FGF signalling pathways in the chick embryo. We
focus on chick anterior frontal area development from E6 to
E16, i.e., at early mesenchymal stage, during calvarial ini-
tiation, bone differentiation, and suture formation. Dlx5
expression profile was compared with the patterns of genes
previously implicated in mouse cranial suture development,
namely Bmp2, Bmp4, Bmp7, FGFRs, Msx1, Msx2, and
Twist. Osteoblast differentiation was assessed by osteopon-
tin gene expression and bone matrix deposition. We show
here that Dlx5 expression is initiated and reinforced in
proliferating preosteogenic cells but not in the differentiated
osteoblasts. Using an explant culture system, we find that
BMP2/4 signalling specifically regulates Dlx5 gene expres-
sion. FGF4 upregulates Bmp4 expression level in the sub-
dermal mesenchyme but is not sufficient to induce Bmp7 or
Fig. 2. Dlx5 is found in a subdomain of FGFR2 and Twist areas. (A–C)
Adjacent transverse E12 sections corresponding to the area boxed in Fig.
1D. Dlx5 overlaps with both Twist and FGFR2 around the bone (A, thick
arrow). FGFR2 and Twist extend further in the mesenchyme (B, thin
arrow), and FGFR2 stains the broadest area, comprising the sutural mes-
enchyme (C, arrowhead).
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Dlx5. Finally, we show that Dlx5 and Msx1 partially over-
lap, and that a putative Dlx5 target gene, Goosecoid, is
expressed within the Dlx5-positive area. We integrate these
data in a model of the genetic network controlling early
avian calvarial development.
Materials and methods
Chick (Gallus gallus, JA 57 strain) E6–E16 embryonic
heads were dissected in ice-cold PBS and used either for
explant culture or fixed for in toto and in situ hybridization
or histological staining for mineralized tissues. In toto skel-
eton staining was realized according to standard procedures,
cartilage being stained with Alcian blue and bone with
Alizarine Red.
In situ and in toto hybridization
For in toto analysis, the dorsal part of the skull was
dissected from its ectoderm and treated as indicated in
Henrique et al. (1995) with a 45-min proteinase K step. For
nonradioactive in situ hybridisation, 7-m-thick paraffin
sections were treated as described in Edom-Vovard et al.
(2001). Double in situ hybridization was revealed by using
INT-BCIP. Some sections were counterstained with Aliza-
rin red. 35S-UTP-labelled in situ hybridization was de-
scribed in Monsoro-Burq et al. (1995). Antisense RNA
probes were synthesized as described previously for chMsx1
and chMsx2 (Monsoro-Burq et al., 1995), chBmp2 and
chBmp4 (Francis et al., 1994); chFGF-R1, -R2 (Wilke et al.
1997); chFGF-R4 (Marcelle et al. 1994); chDlx5 (Pera et
al., 1999); chBmp7 (Wang et al., 1999); mFgf4 (Mahmood
et al., 1995); xnoggin, (Lamb et al. 1993); hBmp2 (Wozney
et al. 1988); and chGoosecoid (Izpisua-Belmonte et al.,
1993). The osteopontin and chTwist probes were kindly
provided by P. Castagnola and M-C. Delfini. The osteocal-
cin fragment was amplified by PCR from published se-
quences.
Cell proliferation detection
E8–E16 embryos were subjected to intracardiac injec-
tion of 1 mg/ml bromo-deoxy-uridine (BrdU) solution and
incubated further for 2 h. Proliferating cells were detected
by using an HRP-anti-BrdU monoclonal antibody detection
kit (Amersham Life Sciences).
Cell and bead implantation into calvaria explants
E9 heads were collected into cold PBS. The lower jaw
and the brain were removed but not the dura mater and the
ectoderm. Cell aggregates were implanted into the mesen-
chyme of the presumptive calvaria as drawn in Fig. 5A.
Explants were cultivated for 36 h, either in serum-free
Dulbecco’s modified Eagle’s medium (DMEM) or in 80%
(v/v) DMEM, 10% (v/v) foetal calf serum, 2% (v/v) chicken
serum. A total of 76 explants were included in this study.
Recombinant human BMP2 was secreted by a quail cell
line containing the defective retrovirus pCRNCM-hBmp2
(Duprez et al., 1996). This vector was shown to direct
production of hBMP2, which is biologically active in the
chick embryo and mimicks both chBMP2 and chBMP4
activities (Monsoro-Burq et al., 1996). Xenopus Noggin
protein was produced by a stable CHO line kindly provided
by R. Harland (Lamb et al., 1993) and shown to block
BMP2/4 signalling in the chick (Monsoro-Burq and Le
Douarin, 2001). The other sources of recombinant factors
were chick fibroblast cells (O-line) transiently transfected
by RCAS retrovirus encoding mBmp4 (Duprez et al., 1996)
or mFGF4 (Edom-Vovard et al., 2001) genes.
Results
Dlx5 is expressed by immature pre-osteoblasts in vivo
The progress of differentiation of the skull was analysed
in entire heads (Fig. 1A–C) and transverse sections in the
nasal–frontal area (Fig. 1A–C). Bone matrix deposition
began at E8.5–E9 in the lateral parts of the frontal and
squamosal bones (Fig. 1A) and progressed medially at E12
(Fig. 1B). The parietal areas began to be ossified at E13 (not
shown). The mineralization process was almost complete by
E16 (Fig. 1C). This oriented and progressive differentiation
was also observed in the frontal–nasal area. At E9, the first
Alizarin red-stained structures were seen laterally to the
nasal septum, adjacent to the optic vesicles (Fig. 1A), the
bony plates progressed medially towards the sagittal plane
and, to a lesser extent, laterally above the optic cups (Fig.
1B, C, and C). This area was chosen for further study on
transverse sections. In this domain, the frontal bones formed
rather close to one another and differentiated rapidly (Fig.
1A–C). The olfactory structures, the nasal septum carti-
lage, and the optic vesicle formed convenient anatomical
cues along the anterior–posterior (AP) axis, from early
stages, before any bone formation can be seen (Fig. 1D).
Bone development proceeded according to an anterior-to-
posterior gradient, allowing to follow the sequential steps of
calvarial development by analysing sections taken at differ-
ent AP levels. Finally, the frontal bones partially overlapped
with the posterior part of the nasal bones, thus allowing the
study of several kinds of bone fusion domains (sutures).
By in toto hybridisation on E9–E12 heads, the nasal and
frontal bones were strongly Dlx5-positive. Posteriorly, only
the edges of frontal, parietal, and squamosal developing
areas, i.e., around the coronal suture, were labelled (not
shown). At E9, the medial part of this posterior area was
devoid of Dlx5 expression; it was thus chosen for the ec-
topic expression assays (see below). Although the egg tooth
or nasal bones were strongly stained, the levels of expres-
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sion in the other skull bones were low and not consistently
obtained.
We next analysed transverse sections from the E6–E16
nasal–frontal area (Fig. 1A–K). Adjacent sections were
stained for Dlx5 (Fig. 1E–H) or the early osteoblast marker
osteopontin (Fig. 1I–K) (Gotoh et al., 1990). We found that
osteocalcin gene expression appeared later than that of
osteopontin (not shown). At E6, we did not detect Dlx5
expression in the loose mesenchyme overlying the brain,
even in the most anterior areas above the olfactory bulbs,
whereas Dlx5 was strongly expressed in the mantle layer of
the developing brain (not shown). Dlx5 appeared at E7, as a
weak signal in the deep parts of dorsal mesenchyme, under
the future dermis, rather broadly distributed (Fig. 1D). At
E8 in anterior areas, and later in more posterior parts, Dlx5
expression was localised as two strong and symmetrical
spots, located on each side of the sagittal plane, in the place
where the bone blastema would form (Fig. 1D and E); this
area was devoid of osteopontin expression (not shown). At
E9, in anterior areas where bone formation had begun (Fig.
1A and I), Dlx5 was excluded from the differentiated os-
teoblasts (compare Fig. 1F with the adjacent section in Fig.
1I). Dlx5 was expressed around the mineralized structure, in
the undifferentiated mesenchyme. The highest levels of
expression were found where the bone followed its major
directions of growth (Fig. 1F). This expression pattern was
maintained from E12 to E16: Dlx5 was found in the mes-
enchymal tissues around the bony pieces, at the main OFs
(Fig. 1G and H). Osteopontin labelled the cells which were
not yet embedded in the bony matrix (Fig. 1J and K). We
did not detect Dlx5 staining in the midsutural mesenchyme
at any of these stages.
We then compared Dlx5 expression with that of Twist
and FGFR2, two genes recorded to be expressed in the
mouse sutural mesenchyme. In adjacent E12 sections, Dlx5
was localised in the Twist, FGFR2 areas close to the
differenciated bone (Fig. 2A–C). However, both Twist and
FGFR2 were also expressed in the mesenchymal cells lo-
cated further apart from the bone elements. Notably, both
are found in the mesenchyme between the nasal and frontal
bones, and FGFR2 was found in the medial part of the
sutural mesenchyme (Fig. 2).
Dlx5 is expressed by proliferating preosteoblasts
The observation that Dlx5 was upregulated before osteo-
blast differentiation and mostly in growing areas suggested
that it might correlate with proliferating osteoblasts precur-
sors. We tested this hypothesis by simultaneously staining
for Dlx5 and BrdU incorporation. At E9 and E12, the dermis
and ectoderm proliferated rapidly (Fig. 3A, C, and F). In the
E9 deep mesenchyme, the immature posterior frontal blast-
emas were formed as two bilateral areas of highly dividing
cells, which overlapped with the Dlx5-positive areas (Fig.
3A and B). The Dlx5-negative mesenchyme located at the
midline (suture), as well as the other parts of this deep
tissue, presented lower BrdU labelling. At E12, the areas of
most active proliferation in the skull forming area also
coincided with the high Dlx5 expression (Fig. 3C and D).
We counted dividing cells and Dlx5-expressing cells in each
area. on several consecutive sections. At E9, the density of
BrdU-positive cells was about three times higher in the Dlx5
domain than in the saggital mesenchyme. In the Dlx5 area,
at E9, 70% of the BrdU-positive cells simultaneously ex-
pressed Dlx5 (n  315, at high magnification, overlapping
Dlx5 and BrdU staining resulted in black-labelled cells, Fig
3B, D, and E; compared with light brown Dlx5-negative
proliferating cells in the dermis, Fig. 3F). We thus con-
cluded that Dlx5 was expressed by actively dividing preos-
teoblasts.
Relationships between Dlx5 expression and BMP and
FGF signalling pathways
In order to understand Dlx5 gene regulation during early
skull development, we compared its expression with that of
a series of molecules known to act in calvarial development
in other vertebrate species. To our knowledge, this is the
first description of these gene patterns, during calvaria de-
velopment in the chick. In particular, we were looking for
factor(s) acting upstream of Dlx5, whose pattern would
account for Dlx5 initial restriction as two distinct bilateral
spots. The analysis of serial alternate sections allowed us to
compare precisely the expression of the different genes in
spite of their dynamic expression profiles (Fig. 4A, sche-
matic of a transverse section).
We focused first on BMP signalling and analysed the
expression of the Bmp2, Bmp4, and Bmp7 genes from E6 to
E16 in the frontal and nasal areas. Bmp4 transcripts were
already detected in the neural crest-derived mesenchyme
from E3 to E5 (not shown). At E6, Bmp4 was found in the
entire dermis area and the meninges but not the deeper
bone-forming area (not shown). Bmp7 was not expressed in
the dorsal mesenchyme at that stage, but was present in the
meninges around the brain. Bmp2 staining was faint and
rather uniformly distributed in the neural crest-derived mes-
enchyme. At E7, Bmp4 was largely expressed in the dermis
and Bmp7 in the ectoderm. The deeper mesenchymal areas
around the nasal cartilage also expressed strong levels of
Bmp4 and began to express Bmp7 transcripts (Fig. 4B). This
area corresponded to the earliest domain expressing Dlx5 in
the future skull (Fig. 1D), thus suggesting that BMP7, or a
combination of BMP4 plus BMP7 signals, could play a role
in the initiation of Dlx5 transcription. Supporting this idea,
Dlx5 was also activated in a subset of the ectodermal areas
positive for Bmp7 gene, whereas no Dlx5 expression was
found in the Bmp4 but Bmp7 dermis. As development
proceeded, gene expression was reinforced and organized
around the differentiating osseous elements. At E9, in the
posterior parts of the still mesenchymal frontal progenitors,
Dlx5 pattern overlapped again with the intersection of Bmp4
and Bmp7 domains, all the expression levels being rein-
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forced as compared with E7 patterns (Fig. 4C and E is
adjacent to Fig. 1E). More anteriorly, at E9, E12, or E16, the
same general features were observed around the differenti-
ating osseous elements, in spite of bone growth and varia-
tions between the very flat nasal bones and the thicker
frontal bones (Fig. 4D and F is adjacent to Fig. 1H and K).
Bmp4 was found almost all around the bone, in the undif-
ferentiated cells lining it, with increased staining at the
growing Dlx5-positive ends (Fig. 4D). Bmp7, in contrast,
was essentially restricted to these ends, with positive cells
found in the mesenchyme close to the bone (Fig. 4F).
Around the rest of the bone, only a very faint Bmp7 staining
was observed. Thus, at the tip of the bony plate, Bmp7 had
a very similar pattern to that of Dlx5, but Dlx5 also extended
farther and at higher levels in the mesenchyme located
around the bone. All over these stages, Bmp2 was ubiqui-
tously expressed at low levels (although slightly above
background levels). In summary, from E6 to E16, Bmp4 and
Bmp7 delineated the forming bones, with enhanced expres-
sion at the OFs. Dlx5 profile comprised these domains and
extended further into the surrounding mesenchyme.
Looking for FGF expression during skull development,
we did not detect Fgf4 and Fgf8 gene expression by in situ
hybridization, although the experiments were sucessfully
made in parallel with positive chick limb sections (Edom-
Vovard et al., 2001), suggesting either no or very low
expression levels in the skull-forming mesenchyme. Thus,
we analysed the expression of chick FGF receptors and
compared it with that of Dlx5 or Bmp genes using serial
alternate sections. At E7, in undifferentiated areas, FGFR-1
gene expression was found in the dermis and the deep
mesenchyme, but excluded from the ectoderm. FGFR-1 was
weaker but overlapping to Bmp4 signals (Fig. 4B). At E9,
FGFR-1 expression was localized adjacent to the Bmp4-
positive area (Fig. 4G). In contrast, at E9, FGFR-2 was not
present in the dermis or in the FGFR-1-expressing areas.
Instead, it was present at low levels all around these do-
mains (Fig. 4I). From E12 onwards, FGFR-1 and FGFR-2
staining were enhanced: FGFR-1 was present all around the
bone and in the recently differentiated cells already sur-
rounded by bone matrix (Fig. 4H), overlapping with os-
teopontin expression domain (not shown). FGFR-2 expres-
sion was found surrounding the bones, external to the
FGFR-1-positive area, in mesenchymal cells negative for
osteopontin (Fig. 2C). From E7 to E16, FGFR-4 was not
expressed in the skull-forming mesenchyme. However, it
strongly stained cartilage elements and muscles (Fig. 4J). In
summary, at early stages, FGF receptor transcripts were not
found in the Dlx5-positive areas at significant levels; later
on, they were located in a subset of the mesenchymal cells
Fig. 3. Dlx5 expressing cells are proliferating. The BrdU staining (brown) overlaps with the Dlx5-positive areas (blue) in the prospective skull mesenchyme
at E9 (A, enlargement in B, E) and E12 (C, enlargement in D). (A, B, E) The E9 section is taken at a posterior level of the frontal area, where no bone or
osteopontin expression is seen yet: the whole bone blastemas express Dlx5. Most of the cells that have just divided also express Dlx5 (arrows in E). A high
rate of proliferation is also present in the dermis (d), which is negative for Dlx5 expression (A, F). (C, D) At E12, Dlx5 strongest staining is found in the
highly proliferative areas, medial to the OFs (arrows). Note the absence of Dlx5 staining in the midsutural mesenchyme(s). Scale bars: (A, C) 416 m; (B,
D) 104 m; and (E, F) 2 m.
182 N. Holleville et al. / Developmental Biology 257 (2003) 177–189
Fig. 4. Bmp4, Bmp7, FGFR-1, and FGFR-2 expression in developing frontal bone. (A) Schematic of a transverse section in the frontonasal area. The area shown in (C–J)
is indicated by the box. (B) Schematic of Bmp gene expression at E7. (C, E, G, I are adjacent to Fig. 1E). (C) At E9, Bmp4 transcripts are found in the dermis (d) and
mesenchymal bone progenitors (arrows). (D) At E16, Bmp4 expression is maintained all around the developing bone, with more intense areas such as the dorsal side of the
bones (asterisks). (E) At E9, Bmp7 expression is strong in the skeletogenic areas of the deep mesenchyme, overlapping with Bmp4 domain (arrows). (F) At E16, Bmp7 is
expressed in the mesenchymal cells surrounding OFs (arrowheads). (G) In E9 areas where bone formation began, a weak FGFR-1 expression appears, adjacent to the Bmp4-
and Bmp7-positive domains (arrows). FGFR-1 is also found in the overlying dermis. (H) At E16, FGFR-1 is strongly expressed in the differentiating cells, both in a thin
layer of mesenchyme lining the bone and in cells embedded into the Alizarin red-stained matrix. (I) At E9, FGFR-2 is low in the areas where the bone appeared (red), which
correspond to the FGFR-1-positive areas (arrows). A widely distributed signal is present in the rest of the mesenchyme. (J, E16) At none of these stages are FGFR-4
transcripts found in the calvaria (b, bone). They are present in muscles and cartilage elements. n.s., nasal septum (F, H, L are counterstained with Alizarin red).
around the bone, in the Dlx5-positive area, without en-
hanced expression in the sites of highest Dlx5 staining. Dlx5
is thus found in a large domain around the bone, comprising
the FGFR-1()/osteopontin() area and included in the
FGFR-2() domain, thus Dlx5 is likely to be expressed
over several determination/differentiation steps in the osteo-
blast lineage.
Dlx5 is regulated by BMP but not by FGF4 signals
We analysed the regulation of Dlx5 gene expression
using explant culture of head dorsal tissues. We used either
cell lines secreting hBMP2, xNoggin, or cells transiently
transfected with RCAS viruses and secreting mBMP4 or
mFGF4. The effect of overexpressing BMPs was tested by
implanting the cells posterior to the presumptive frontal
bones, in an immature area devoid of Dlx5 expression (Fig.
5A). BMP2 overexpression was followed by the induction
of ectopic Dlx5 expression around the graft (n  20/22),
whereas control cells never caused Dlx5 overexpression
(Fig. 5B). Sections showed induction both in the deep mes-
enchyme, under the dermis and in the ectoderm (Fig. 5C).
This result was obtained with the BMP2 cell line, which
secretes high amounts of BMP2 protein, whether or not
serum was added in the culture medium (n  12/13 cases of
induction without serum). In two cases, the BMP2 implant
also induced an osseous-like structure expressing low levels
of the osteopontin gene (not shown). When the implants
were inserted in an even more immature area, such as the
center of the coronal suture, no induction was observed (n
4/4, not shown). If the mBMP4-RCAS-transfected cells
were grafted, we did not observe effective Dlx5 induction (n
 1/6). This might be due to the lower levels of protein
produced under the control of the RCAS promotor, com-
pared with the CMV promotor, as shown in other circum-
stances. Alternatively, exogenous BMP2 might be able to
mimick the effects of both BMP7 and BMP4, whereas
BMP4 alone could not do so.
The requirement for BMP signalling for Dlx5 expression
was tested by implanting Noggin-secreting cells into a more
mature area, nearby where the frontal bones were undergo-
ing differentiation, but still into undifferentiated tissues
(Fig. 5A). The blocking of BMP signalling was followed by
a strong downregulation of Dlx5 expression, especially in
the most immature areas, towards the saggital plane (n 
5/7, Fig. 5D and E, compare the left grafted side with the
nonoperated right side in D). Control cells did not prevent
the onset of Dlx5 expression. These two results show that
BMP signals are necessary and sufficient for Dlx5 induc-
tion. When the Noggin cells were implanted into areas
already expressing Dlx5, no downregulation was noticed:
BMPs are not likely to take part in the maintenance of Dlx5
expression (not shown).
Since several FGF receptors were found in the areas
where Dlx5 was activated, we overexpressed mFGF4 in the
immature posterior area (Fig. 5A). The position of the graft
was the same as these with BMP sources. Around the
implant, a strong Bmp4 gene expression was induced (Fig.
5F, n  5/8) as compared with the normal expression level
in this area (Fig. 5H). However neither Dlx5 (Fig. 5G) nor
Bmp2 or Bmp7 (not shown) were induced by mFGF4 (n 
0/8). Together, these data show that Dlx5 induction is spe-
cifically regulated by BMP signals. This was achieved ex-
perimentally by providing high amounts of BMP2 in an
immature area.
Goosecoid and Msx1 are also present in the early
calvarial structures
The Dlx5 mutant mouse presents reduced Goosecoid
gene expression in frontonasal and branchial areas and their
facial skeleton has similarities to that of the Goosecoid
defective embryos, suggesting that Dlx5 might regulate
Goosecoid gene transcription (Depew et al., 1999). Looking
for potential targets of Dlx5 in the skull progenitors, we
found that Goosecoid was expressed at E12, in the undif-
ferentiated mesenchymal cells around bone, in a pattern
similar to that of Dlx5, although at lower levels (Fig. 6A and
B). Goosecoid was also present in the dermis (not shown)
and in the mesenchyme expressing Twist and FGFR2 (Fig.
2). At E9, we did not detect any significant levels of
Goosecoid transcripts in the early mesenchymal proliferat-
ing cells expressing Dlx5. We also tested whether BMP2-
induced Dlx5 ectopic expression was sufficient to induce
Goosecoid ectopically, but did not observe any induction in
these conditions (not shown), suggesting the need for addi-
tional factors and/or acting on more mature cells.
DLX5 protein was shown to interact with MSX1 and
MSX2 factors and to modulate target gene activity. We
analysed Msx gene expression in the chick nasal–frontal
area from E7 to E16. Msx1 was continuously expressed in
the neural crest-derived mesenchyme from early E3 stages
(not shown). At E6 and E7, it was found in the deep
mesenchymal domain expressing Bmp4 (not shown, as in
Fig. 4B). At E9, Msx1 was not found in the posterior
proliferating Dlx5–Bmp-positive mesenchyme. At anterior
levels, however, where bone had started to form, Msx1 was
found expressed in a pattern very similar to that of Bmp4,
i.e., in a domain included in the larger Dlx5-positive area.
Msx1 pattern presented subtle differences to that of Dlx5.
For example, Msx1 was not detected at the tips of the bony
plates (Fig. 6A and C), but rather in the areas of lower Dlx5
activity, along the dorsal face of the osseous plate, as was
Bmp4. These overlapping but distinct patterns suggest that
differential interactions between DLX5 and MSX1 proteins
occur locally, around the bony elements. This might lead to
a fine control of the skull morphogenesis. Finally, we tried
to analyse whether MSX1 could directly control Dlx5 gene
expression by implanting cells transfected with a competent
chMsx1-RCAS retrovirus (D Duprez, unpublished observa-
tions). Unfortunately, the Dlx5-negative implantation area
also presented low levels of proliferation; this did not allow
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the spread of the virus into the host tissues and thus pre-
vented us from doing this analysis. By nonradioactive in situ
hybridization, in spite of high expression levels in other
tissues, we did not detect Msx2 expression in the presump-
tive skull before E16: it was then found in the remodeling
bone (not shown). It was only by increasing sensitivity by
using the radioactive in situ hybridization technique that we
found a faint Msx2 expression in the E10–E12 midsaggital
mesenchyme, and lining some skeletal elements (Fig. 6D).
Msx2 was not detected at the OFs or in other Dlx5-positive
areas.
Discussion
Dlx5 is expressed at several stages of osteoblasts
development
Our results provide a scheme of the gene expression
changes during progressive osteoblast development (Fig.
7A). In the mouse embryo, FGFRs are differentially ex-
pressed at different stages of osteoblast development.
FGFR-2 and Twist are present on proliferating precursors,
whereas early differentiating cells are associated with
FGFR-1 transcripts (Anderson et al., 1998; Iseki et al.,
1999; Fragale et al., 1999). We show here that Dlx5 is
expressed by at least three distinct populations of the osteo-
blast lineage. FGFR-2 and Twist expression are found in the
nondifferentiated sutural mesenchyme and surrounding the
bones, thus in a larger domain than that of Dlx5 (Figs. 1, 2,
and 6A). This suggests that the early population of Dlx5
cells corresponds to the more mature FGFR-2Twist cells.
Closer to the bone, Dlx5 overlaps with Bmp7 expression,
defining a second Dlx5 population. Finally, FGFR-1 is
found in a thin layer external to the mineralised bone as well
as in the recently embedded osteopontin-positive cells
(Figs. 1 and 4). The most external part of the FGFR-1-
Fig. 5. Regulation of Dlx5 by BMP2, Noggin, and FGF4. (A) Schematic of
the grafts in the head explants. Control immature mesenchyme (orange)
does not express Dlx5, whereas the more mature area (green) would
normally express Dlx5 (blue domains) by the time of fixation. (B) Dlx5 is
induced (orange arrow) after implantation of BMP2-secreting cells but not
around control cells (black arrow), both grafted in the posterior immature
area (asterisk indicate the cell aggregates). (C) On transverse sections
through an immature area grafted with BMP2 (orange arrow, Bmp2 mRNA
in red), Dlx5 is induced in the ectoderm (arrowhead) as well as in the deep
mesenchyme (arrows). (D) After the implantation of Noggin-producing
cells in the more mature area (green arrow, Noggin mRNA in red), Dlx5
expression is strongly downregulated around the graft, especially in the
medial area (underline in “a”). On the contralateral side, a robust Dlx5
expression is detected (underline “b”, the saggital plane is indicated). (E)
General view of (D). The saggital plane is positioned according to the brain
hemispheres. (F) After the graft of FGF4-secreting cells (orange arrow,
FGF4 mRNA in red), a strong induction of Bmp4 expression is observed
(arrows, compare with the low or lack of staining in control areas (H). (G)
In contrast, similar FGF4 implants (orange arrow) do not induce ectopic
expression of Dlx5.
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expressing area overlaps with the Dlx5 domain, whereas
Osteopontin/FGFR-1 cells surrounded with bone matrix
do not (Fig. 7A). Thus, Dlx5 is not present in the undiffer-
entiated sutural mesenchyme and is present in proliferating
but not differentiating preosteoblasts, then in early osteo-
blasts. When osteoblast cell lines were derived from various
tissues, they were likely to be at one of these stages. The
upregulation of the osteocalcin gene by Dlx5 observed by
Miyama et al. (1999) could reflect DLX5 activity in the
FGFR-1-positive subpopulation, while the repression of os-
teocalcin by DLX5 (Ryoo et al., 1997) might occur in the
proliferating FGFR2/FGFR1 mesenchymal population.
Moreover, in these cell lines, DLX5 function might be
modified by the presence of interacting proteins, such as
MSX1 or MSX2, which are negative modulators of DLX5
activity (Zhang et al., 1997; Newberry et al., 1998). We
showed here that Msx1 gene was expressed in a subdomain
of the Dlx5-positive area, supporting the idea that local and
mutual modulation of these gene activities occurred around
the developing bone.
Dlx5 gene regulation in the avian calvarial mesenchyme
Several signalling cascades have been described at the
level of the mouse osteogenic fronts. We show here that
Dlx5 is part of the BMP signalling pathway regulating
calvarial development. Dlx5 is specifically induced by BMP
signalling but not by FGF signals. These results when high
levels of BMP2 were provided, suggesting that the endog-
enous BMP signalling, might be achieved differently. Het-
erodimers of BMPs act more potently than homodimers in
several instances. BMP2/BMP7 or BMP4/BMP7 het-
erodimers have been implicated in several developmental
mechanisms (Suzuki et al., 1997; Nishimatsu and Thomsen,
1998; Schmid et al., 2000). Notably, BMP4/7 heterodimers
potently induce intramembranous bone formation in vitro
and in ectopic locations in adult rats (Aono et al., 1995).
Consistent with these data, we see high Dlx5 activation
where Bmp4 and Bmp7 genes are coexpressed. Depriving
the tissues of BMP2/BMP4 activity locally blocked Dlx5
activation in the osteogenic mesenchyme. It would be in-
teresting to do the converse experiment, blocking BMP7
activity by using a potent source of follistatin, a specific
BMP7 antagonist, to analyse the requirement for this factor
on Dlx5 expression.
BMP and FGF pathways activate a common target,
Msx1, in several neural crest-derived tissues: murine cal-
varia and tooth mesenchyme (Kim et al., 1998; Bei and
Maas, 1998). Although we did not detect Fgf4 or Fgf8 gene
expression, a recent study localised endogenous FGF2 pro-
tein in the chick calvarial mesenchyme, showing elevated
levels in the nondifferentiated mesenchyme, around the
bones and in the sutural mesenchyme (Moore et al., 2002).
Since we found that FGFR-1 and FGFR-2 were expressed
from E6–E7 onwards, in all the neural crest-derived mes-
enchyme then at the OFs, FGF signalling is also likely to be
active at various steps of calvarial formation. However, our
experimental overexpression of FGF4 did not activate Dlx5
in the early sutural mesenchyme. In mice embryos, FGF2
activates Twist gene expression in the midsutural mesen-
chyme and at the OFs (Rice et al., 2000). We show here
that, in the chick, Dlx5 and Twist patterns overlap in the area
of most intensive cell proliferation, near the OFs. However,
Twist is more largely distributed and included in the larger
FGFR-2 domain.
Fig. 6. Expression of Dlx5, Goosecoid, Msx1, and Msx2 at E12. Adjacent
E12 transverse sections are stained for Dlx5 (A), Goosecoid (B), or Msx1
(C) gene expression. (B) Goosecoid is detected in a pattern similar to that
of Dlx5 (A), although more diffuse. (C) In this area, Msx1 is present at the
dorsal and ventral edges of the bony plate, but absent from the OFs
(arrows). (D) Radiolabeled in situ hybridization evidences Msx2 transcripts
in the ventral part of the bony plate (arrows). None of these genes is
expressed in the midsutural mesenchyme (s).
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Early relationship between BMP and FGF pathways
BMP and FGF signalling have been implicated sepa-
rately in suture development in the mouse. Here, we have
shown that at earlier stages, in the yet undifferentiated head
mesoderm, FGF4 was able to activate Bmp4 but not Bmp7
gene expression. FGFR-1 and FGFR-2 expression patterns
from E6 to E7 are consistent with a role of this pathway in
Bmp4 activation and/or maintenance from these early
stages. In another system, it was shown that FGF signalling
modulated negatively Bmp4 gene expression: FGFR-3 over-
expression results in the downregulation of Bmp4 expres-
sion in the growth plate cartilage and block endochondral
bone growth (Naski et al., 1998). This suggests that differ-
ent regulatory responses can occur in the different types of
skeletogenic differentiation and/or at different stages of
these differentiation processes.
This study has focused on Dlx5 regulation from the early
steps of the osteogenic mesenchyme formation up to suture
formation in the avian embryo. We propose a model inte-
grating our results (Fig. 7B, our data are shown in black)
together with data obtained in the mouse embryo which are
Fig. 7. Gene expression and regulation during chick calvaria development. (A) We have summarised the overlapping expression patterns analysed here and
integrated them with the different steps of the differentiation of the osteoblasts. (B) A model of the gene interactions implicated in Dlx5 regulation.
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likely to be modulate the BMP-Dlx5 pathway in avians as
well (grey, Kim et al., 1998 and Opperman, 2000; hypo-
thetical interactions are italicized, or indicated in green).
The factor(s) responsible for Bmp7-localised activation in
the deep mesenchyme is still unknown, but our results
showed that high levels of FGF4 were not sufficient to do
so; we hypothesize that non-FGF signal might be involved.
In vivo, the combination of BMP7 and BMP4 (with a
potential contribution of ubiquitously expressed BMP2) is
likely to induce Dlx5 in localised areas of the head mesen-
chyme expressing FGFR2 and Twist. These restricted areas
present a high rate of proliferation and are fated to become
bone. In parallel, FGF2/4 and BMP4 have been shown to
induce Msx1, at later stages of calvarial development (Kim
et al., 1998). Although understanding the role of the DLX5
protein in the DLX5–MSX1 interactions in this system
awaits further studies, we propose that these interactions
would establish a regulatory loop that modulate the prolif-
eration level versus the differentiation status of the osteo-
blasts, ultimately leading to the proper morphogenesis of
the skull bones.
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